FrancisKBuadiMD

PubMed

• 137 citations
  Systemic amyloidosis from A (AA) to T (ATTR): a review.
  Eli Muchtar, Angela Dispenzieri, Hila Magen, Martha Grogan, Michelle L. Mauermann
  Journal of Internal Medicine. 2021-03-01
• 1789 citations
  Improved survival in multiple myeloma and the impact of novel therapies
  Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman
  Blood. 2008-03-01
• 52 citations
  Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
  Sutapa Sinha, Dennis A. Gastineau, Ivana N. Micallef, William J. Hogan, S. M. Ansell
  Bone Marrow Transplantation. 2011-07-01

Journal Articles

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Quantification of clonal circulating plasma cells in relapsed multiple myeloma  
  Gonsalves WI, Morice WG, Rajkumar V, Gupta V, Timm MM, Dispenzieri A, Buadi FK, Lacy MQ, Singh PP, Kapoor P, Gertz MA, Kumar SK, Br J Haematol, 8/12/2014
• Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT (Bone Marrow Transplantation)  
  Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi FK, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N, Bone Marrow Transplant, 1/1/2014
• A review of poems syndrome  
  Dispenzieri A, Buadi FK, Oncology, 12/1/2013
• Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate (Letter)  
  D'Souza A, Theis JD, Vrana JA, Buadi FK, Dispenzieri A, Dogan A, Am J Hematol, 11/1/2012
• Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immunemod...  
  Dispenzieri A, Dingli D, Kumar SK, Rajkumar SV, Lacy MQ, Hayman S, Buadi FK, Zeldenrust S, Leung N, Detweiler-Short K, Lust JA, Russell SJ, Kyle RA, Gertz MA, Am J Hematol, 10/1/2010
• Acaseof bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia  
  Leung N,Buadi FK, Song KW, Magil AB, Cornell LD, NDT Plus, 1/1/2010
• Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma maybe associated with prolonged survival  
  Lacy MQ, Mandrekar S, Dispenzieri A, Hayman S, Kumar S, Buadi FK, Dingli D, Litzow M, Wettstein P, Padley D, Kabat B, Gastineau D, Rajkumar SV, Gertz MA, Am J Hematol, 12/1/2009
• Anthracyclines survive targeted therapy - The Ning/He/Dagher et al article reviewed (Editorial)  
  Buadi FK, Rajkumar SV, Oncology (Williston Park), 11/1/2007
• Myelodysplastic syndrome: new insight into treatment  
  Baudi FK, Fellow Reporter, 6/1/2001
• Conflicts of interest, authorship, and disclosures in industry-related scientific publications  
  Fonseca R, Richardson P, Giralt S, Lonial S, Rajkumar SV, Stewart AK, Bensinger W, Somlo G, Vescio R, Mikhael J, Reeder C, Tiedemann R, Tricot G, Rifkin R, Shaughnessy..., Mayo Clin Proc
• Join now to see all

Books/Book Chapters

• Multiple myeloma: diagnosed and treatment 
  Chapter: Management of treatment complications and supportive care 
  Page 159 - 177Buadi FK, Chanan Khan AEditors: Gertz MA; Rajkumar SV.Springer, New York, NY2014
• Wintrobe's clinical hematology 
  Chapter: Practical approch to evaluation of monoclonal gammopathies 
  Page 2014 - 2021Buadi FK, Mikhael JR, Morice WGWolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PAEdition 13th,2014
• Hematology: basic principles and practice 
  Chapter: Immunoglobin light-chain amyloidosis (primary amyloidosis) 
  Page 1350 - 1374Gertz MA, Buadi FK, Zeldenrust SR, Hayman SREditors: Hoffman R; et al.Saunders/Elsevier, Philadelphia, PAEdition 6th,2013
• Amyloidosis: diagnosis and treatment 
  Chapter: Conventional treatment of amyloidosis 
  Page 155 - 164Gertz MA, Buadi FKEditors: Gertz MA; Rajkumar SV.Humana Press, New York, NY2010
• Amyloidosis: diagnosis and treatment 
  Chapter: Localized amyloidosis 
  Page 95 - 106Buadi FKEditors: Gertz MA; Rajkumar SV.Humana Press, New York, NY2010
• Myeloma therapy: pursuing the plasma cell 
  Chapter: Thalidomide: induction therapy 
  Page 229 - 237Buadi FK, Rajkumar SVEditors: Lonial S.Humana Press, Totowa, NJ2008
• Join now to see all

Abstracts/Posters

• A phase ll study (px-171-003-a1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma
  Siegel D, Martin T, Wang M, Vij R, Jakubowiak A, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu F, Somlo G, Zonder J, Stewart AK, Stad..., Onkologie, 10/1/2013
• Prediction of poor mobilization of autologous cd34+cells in multiple myeloma (mm): implications for risk-stratification
  Costa LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, Kang Y, Gertz MA, Stuart RK, Kumar SK, Transfusion, 9/1/2013
• A phase II study (PX-171-003-A1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma (rrmm)
  Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu FJ, Somlo G, Zonder J, Song K, Stewa..., Br J Haematol, 4/1/2013
• Suppression of involved immunoglobulin free light chain post therapy and survival outcomes following autologous stem cell transplantation for myeloma
  Smeltzer J, Gertz M, Rajkumar SV, Dispenzieri A, Lacy M, Buadi FK, Hayman S, Dingli D, Kapoor P, Kumar S, Biol Blood Marrow Transplant, 2/1/2013
• Redefining engraftment syndrome: the new Mayo Clinic criteria
  Burnette BL, Gertz M, Kumar S, Lacy M, Buadi FK, Hayman S, Dingli D, Inwards DJ, Johnston PB, Micallef IN, Porrata LE, Hogan W, Litzow MR, Patnaik M, Hashmi S, Leung N..., Biol Blood Marrow Transplant, 2/1/2013
• Outcomes of patients with POEMS syndrome treated initially with radiation
  Humeniuk M, Gertz MA, Lacy MQ, Kyle RA, Hayman SR, Kumar SK, Lust JA, Witzig TE, Buadi FK, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Kapoor P, Leung N, ..., Blood, 11/16/2012
• Importance of achieving sustained stringent complete response (scr) following autologous stem cell transplantation in multiple myeloma
  Kapoor P, Gertz MA, Dispenzieri A, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Russell S, Lin Y, Witzig TE, Lust JA, Zeldenrust SR, Greipp PR, Kyle RA, Rajkumar V, Kumar SK, Blood, 11/16/2012
• Phase i/ii, multicenter, open-label, dose-escalation study of bendamustine in combination with lenalidomide and dexamethasone (brd) in patients with relapsed multiple ...
  Kumar SK, Krishnan A, Roy V, Zimmerman TM, Gertz MAA, Stockerl-Goldstein KE, Buadi FK, Rosenbaum C, Birgin A, Fiala M, Jiminez V, Maharaj M, Needle MN, Vij R, Blood, 11/16/2012
• Pomalidomide plus low-dose dexamethasone (POM/DX) in relapsed myeloma: long term follow up and factors predicing outcome in 345 patients
  Lacy MQ, Kumar SK, LaPlant BR, Laumann K, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Lust JA, Russell S, Dingli D, Zeldenrust SR, Fonseca R, Bergsagel PL, Stewart K..., Blood, 11/16/2012
• Phase 1b/2a open-label, multiple-dose, dose-escalation study to evaluate the safety and tolerability of sns01-t administered by intravenous infusion in patients with r...
  Lust JA, Usmani SZ, Hamadani M, Barranco C, Lacy MQ, Dispenzieri A, Gertz MA, Dingli D, Russell S, Buadi FK, Zeldenrust SR, Hayman SR, Rajkumar SV, Kumar SK, Thompson ..., Blood, 11/16/2012
• Results from the phase II dose expansion of cyclophosphamide, carfilzomib, thalidomide and dexamethasone (cyclone) in patients with newly diagnosed multiple myeloma
  Mikhael JR, Reeder CB, Libby EN III, Costa LJ, Bergsagel PL, Buadi FK, Mayo A, Gano K, Wolf C, Dueck AC, Stewart AK, Blood, 11/16/2012
• Survival after second, third, and fourth line therapy better than expected in patients with previously treated al amyloidosis who were not transplant candidates at dia...
  Raval GG, Gertz MA, Lacy MQ, Hayman SR, Kumar SK, Buadi FK, Lust JA, Zeldenrust S, Dingli D, Hall RL, Hwa L, Lin Y, Kapoor P, Witzig TE, Kyle RA, Russell S, Leung N, R..., Blood, 11/16/2012
• Incidence of cardiac arrhythmias during autologous peripheral blood stem cell transplantation
  Singla A, Hogan WH, Ansell SM, Buadi FK, Dingli D, Dispenzieri A, Gastineau DA, Gertz MA, Hayman SR, Inwards DJ, Johnston PB, Lacy MQ, Litzow MR, Micallef IN, Porrata ..., Biol Blood Marrow Transplant, 2/1/2012
• Phase ii trial of intravenously administered amd3100 (plerixafor) for stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transpla...
  Kumar S, Mikhael J, Lacy M, LaPlant B, Buadi FK, Dingli D, Gertz M, Miceli T, Bergsagel L, Hayman S, Reeder C, Stewart K, Dispenzieri A, Gastineau D, Winters J, Biol Blood Marrow Transplant, 2/1/2012
• The depth of renal response strongly predicts overall surival in patients with al amyloidosis
  Glavey SV, Dispenzieri A, Gertz MA, Kumar S, Lacy MQ, Buadi FK, Rajkumar SV, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Dingli D, Hall RL, Leung N, Blood, 11/18/2011
• The utility of high sensitivity cardiac troponin among patients with immunoglobulin light chain amyloidosis
  Dispenzieri A, Gertz MA, Saenger AK, Grogan M, Kumar S, Lacy MQ, Kyle RA, Leung N, Zeldenrust S, Hayman SR, Buadi FK, Greipp PR, Rajkumar SV, Russell S, Dingli D, Lust..., Blood, 11/18/2011
• Long term outcomes of pomalidomide and dexamethasone in patients with relapsed multiple myeloma: analysis 4 years after the original cohort
  Mikhael JR, Hayman SR, Laumann K, Roy V, LaPlant BR, Kumar S, Buadi FK, Reeder CB, Gertz MA, Dispenzieri A, Lust JA, Stewart AK, Russell S, Bergsagel PL, Dingli D, Zel..., Blood, 11/18/2011
• Survival outcome of young multiple myeloma (MM) patients in the era of novel therapies
  Kapoor P, Gertz MA, Rajkumar SV, Lacy MQ, Dingli D, Hayman SR, Russell SJ, Lust JA, Buadi FK, Zeldenrust SR, Greipp PR, Dispenzieri A, Kyle RA, Kumar S, Blood, 11/18/2011
• Phase II trial of intravenously administered AMD3100 (plerixafor) for stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transpla...
  Kumar S, Mikhael JR, Lacy MQ, LaPlant BR, Buadi FK, Dingli D, Gertz MA, Miceli T, Mahlman M, Bergsagel PL, Hayman SR, Reeder CB, Dispenzieri A, Gastineau DA, Winters J, Blood, 11/18/2011
• A phase I trial of zevalin radioimmunotherapy with high-dose melphalan (HDM) and autologous stem cell transplant (ASCT) for multiple myeloma (mm)
  Dispenzieri A, Gertz MA, Lacy MQ, Laumann K, LaPlant BR, Kumar S, Buadi FK, Hayman SR, Dingli D, Hogan WJ, Ansell SM, Gastineau DA, Inwards DJ, Micallef IN, Porrata LF..., Blood, 11/18/2011
• Relapse of poems following autologous stem cell transplantation: a single center experience
  D'Souza A, Buadi FK, Lacy MQ, Gertz MA, Hayman SR, Kumar S, Dingli D, Zeldenrust SR, Dispenzieri A, Blood, 11/18/2011
• Pomalidomide and dexamethasone in relapsed myeloma: results of 225 patients treated in five cohorts over three years
  Lacy MQ, LaPlant BR, Laumann K, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Kumar S, Lust JA, Russell S, Dingli D, Zeldenrust SR, Greipp PR, Fonseca R, Bergsagel PL,..., Blood, 11/18/2011
• Factors predicting early mortality in patients with newly diagnosed multiple myeloma
  Rana V, Srivastava G, Hayman SR, Buadi FK, Gertz MA, Lacy MQ, Greipp PR, Zeldenrust SR, Dispenzieri A, Kyle RA, Lust JA, Short KD, Dingli D, Russell SJ, Rajkumar SV, K..., Blood, 11/18/2011
• The timing of acute renal failure strongly affects survival of immunoglobulin light chain (AL) amyloidosis patients undergoing autologous stem cell transplantation
  Leung N, Kumar S, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Glavey SV, Gertz MA, Blood, 11/18/2011
• Matched case control analysis comparing long term survival of multiple myeloma patients who received stem cell transplant with and without idiotype-pulsed dendritic ce...
  Lin Y, Gertz MA, Sims RB, Mandrekar S, Laumann K, LaPlant B, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Padley D, Gastineau DA, Kumar S, Rajkumar V, Lacy MQ, Blood, 11/18/2011
• Join now to see all

Lectures

• Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 
  Mayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013
• Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 
  Mayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013

Other

• Vital statistics, maternal mortality and causes of childhood mortality in the Tanoso district, Brong Ahafo region, Ghana (Thesis) 
  Buadi FK, School of Medical Sciences, University of Science and Technology
  Kumasi, Ghana - 8/1/1990
• Polyclonal Hypergammaglobulinemia 
  Buadi FK, Ask Mayo Expert
  http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=4592